ACLOFIX-S

This brand name is authorized in Nigeria.

Active ingredients

The drug ACLOFIX-S contains a combination of these active pharmaceutical ingredients (APIs):

1	Aceclofenac UNII RPK779R03H - ACECLOFENAC
	Aceclofenac is a non-steroidal agent with marked anti-inflammatory and analgesic properties. The mode of action of aceclofenac is largely based on the inhibition to prostaglandin synthesis. Aceclofenac is a potent inhibitor of the enzyme cyclo-oxygenase, which is involved in the production of prostaglandins.
	Read more about Aceclofenac
2	Serratiopeptidase UNII NL053ABE4J - SERRAPEPTASE

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-9181	Tablet	ACLOFIX - S TABLET TAB 100 mg; 15 mg 1 X 10, 10 X 1 X 10	168 RNW-PP-327474 ACLOFIX - S TABLET ACECLOFENAC + SERRATIOPEPTIDASE Acelofenac BP 100mg Serratiopeptidase 15mg B4-9181 Drugs Imported Products 110,10110 Prescription Only Medicine (POM) 5/2/2023 AQUATIX PHARMACEUTICALS LIMITED, 7, Sapara Williams Street, Industrial Estate, Ikeja. Lagos. Nigeria. 7064946450 aquatixnigeria@gmail.com M/S GLOBELA PHAMA PVT LTD of 357, GIDC SACHIN, SURAT, GUJARAT, INDIA, 357, GIDC SACHIN, SURAT, GUJARAT, INDIA, India	21/12/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M01AB16	Aceclofenac	M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AB Acetic acid derivatives and related substances
Discover more medicines within M01AB16

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-9181